TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/20/25 17:34 | 5/16/25 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibney Anthony S | MA | O | See Rema | P.d | 245 | 4.90 | 0 | 50 | 721 | 57 | D | ||||||||||||||
5/20/25 17:34 | 5/16/25 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibney Anthony S | MA | O | See Rema | S.d | -8 | 5.15 | 0 | -2 | -3 | 57 | D | ||||||||||||||
4/19/24 09:45 | 4/17/24 | CLSD | Clearside Biomedical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gibney Anthony S | GA | D | P.m | 130 | 1.30 | 0 | 100 | New | 100 | D | |||||||||||||||
12/14/22 16:28 | 12/13/22 | ISEE | Iveric Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gibney Anthony S | NJ | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 31 | 263 | 43 | D | ||||||||||||||
7/5/22 18:30 | 6/30/22 | ISEE | Iveric Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gibney Anthony S | NJ | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 19 | 11 | D | |||||||||||||||
7/5/22 18:30 | 7/5/22 | ISEE | Iveric Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gibney Anthony S | NJ | O | EVP,Chie | S.d | -73 | 9.41 | 0 | -8 | -42 | 11 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |